Back to News
Market Impact: 0.3

Guru Fundamental Report for JNJ

JNJNDAQ
Company FundamentalsAnalyst InsightsHealthcare & BiotechMarket Technicals & Flows
Guru Fundamental Report for JNJ

Validea's guru fundamental report indicates JOHNSON & JOHNSON (JNJ) receives an 87% rating based on their Multi-Factor Investor model, which is based on the strategy of Pim van Vliet and favors low volatility stocks with strong momentum and high net payout yields; this suggests the strategy has interest in the stock due to its underlying fundamentals and valuation.

Analysis

Johnson & Johnson (JNJ) has received an 87% rating from Validea's Multi-Factor Investor model, a strategy developed by Pim van Vliet that prioritizes low volatility stocks also exhibiting strong momentum and high net payout yields. This score, above the 80% threshold typically indicating strategy interest, reflects positively on JNJ's underlying fundamentals and valuation as a large-cap growth stock within the Biotechnology & Drugs industry. The model specifically confirmed JNJ's suitability based on its market capitalization and standard deviation, resulting in a "PASS" for its final rank. However, the analysis also flagged "NEUTRAL" assessments for JNJ's "Twelve Minus One Momentum" and "Net Payout Yield," suggesting these specific factors are not primary drivers of the positive rating but do not significantly detract. The overall sentiment surrounding this assessment is strongly positive, with JNJ receiving a specific sentiment score of 0.8, underscoring the favorable view derived from this quantitative model which aligns with van Vliet's research into conservative factor investing.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.60

Ticker Sentiment

JNJ0.80
NDAQ0.00

Key Decisions for Investors

  • Investors employing factor-based strategies, particularly those targeting low-volatility and conservative growth profiles, should consider Johnson & Johnson given its favorable 87% rating from the Pim van Vliet-based Multi-Factor Investor model.
  • It is advisable to conduct further due diligence on Johnson & Johnson's current momentum and net payout yield, as these registered as neutral within the model, to ensure these aspects align with specific investment objectives despite the overall positive assessment.
  • While the 87% score indicates notable interest from the strategy, investors might weigh this against the model's indication that scores above 90% represent strong interest, potentially positioning JNJ as a candidate for monitoring or a moderate allocation.